With telehealth access to GLP-1s now commonplace and prices significantly lower, patient retention will hinge on trust and rapport with providers, an easy online/app-based experience, and consistent follow-up support for medication and side-effect management
Tirzepatide expanded the concept by combining GIP and GLP-1 receptor agonism, while retatrutide adds glucagon receptor agonism as a third axis
Furthermore, these substantial results are typically realized over a specific timeframeoften 68 weeksemphasizing that this is a long-term medical journey, and success requires patience, strict adherence, and the close supervision of a medical professional
A TRT + Sermorelin stack might be a smart fit if: And bonus: Sermorelin doesnt suppress testosterone, doesnt cause water retention like HGH, and is well-tolerated by most men
Analysts estimate the sector could exceed $100 billion in value by the 2030s
Patients should increase home glucose monitoring frequency during the transition period and work with their healthcare provider to adjust or initiate alternative diabetes medications as needed